Meta is rated a Strong Buy, with current valuation dislocation driven by accounting noise and misunderstood CapEx cycles.

Johnson & Johnson has submitted a Type II variation application to the European Medicines Agency for an extension of ...

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...

MSCI’s rule change on newly issued shares reshapes passive demand, raising questions over how Bitcoin-linked treasury firms ...

Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...

In summary, we are making significant strides in advancing BOT/BAL and positioning Agenus for long-term success. I'll now ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...

Ex-CFTC Commissioner Brian Quintenz joined SUI Group Holdings’ board. SUI price has broken the $1.80 resistance with strong ...

Consolidation is expected to continue in the market for the next few sessions. Below are some short-term trading ideas to ...

December, the proposal recommends allocating not less than 5% of unlocked WLFI holdings toward incentives for centralized and ...

According to MarketsandMarkets™, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion ...

Rising U.S.-China tensions over Venezuelan oil weigh on CSI 300 and Hang Seng, though hopes of Beijing stimulus continue to ...